UBS Group
CDAK

UBS Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

UBS Group’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$16 Hold
2022
Q4 		$36 Sell
2022
Q3 		$0 Sell
2022
Q2 		$2K Buy
2022
Q1 		– Sell
2021
Q4 		$41K Sell
2021
Q3 		$91K Sell
2021
Q2 		$139K Sell
2021
Q1 		$116K Sell
2020
Q4 		$278K Buy